Dielectric Property Test Compared With Frozen Pathological Section in the Rapid Diagnosis of Lung Nodules/Mass

NCT03339479 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 502

Last updated 2018-10-30

No results posted yet for this study

Summary

Patients with lung nodules/mass found by CT (computed tomography) or PET (positron emission tomography) who agree to receive lung resection are arranged to test the dielectric property before receiving the frozen pathological examination. And the final pathological results are recognized as the standard diagnosis. Then the sensitivity and specificity of the dielectric property test will be evaluated comparing with the frozen pathological examination.

Conditions

  • Lung Nodules
  • Lung Mass

Interventions

DIAGNOSTIC_TEST

dielectric property test

Test the dielectric property of resected lung nodules/mass through a touching probe after the lung tissue with nodules/mass has been resected and cut open, which usually takes only 1-5 minutes.

DIAGNOSTIC_TEST

frozen pathological examination

And after the dielectric property test, the lung tissue will be sent for frozen pathological examination.

DIAGNOSTIC_TEST

final pathological examination

All of the lung nodules/mass will be diagnosed by final pathological examination and recognized as the final diagnosis after surgery.

Sponsors & Collaborators

  • Nanfang Hospital, Southern Medical University

    lead OTHER

Principal Investigators

  • Di Lu, MD,PhD · Nanfang Hospital, Southern Medical University

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-25
Primary Completion
2020-05-24
Completion
2020-05-24

Countries

  • China

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03339479 on ClinicalTrials.gov